← FDA DRUG APPROVALS

FDA ANDA · ANDA204590

CELECOXIB

Sponsor: MACLEODS PHARMS LTD

APPLICATION
ANDA204590
TYPE
ANDA
ORIGINAL APPROVAL
2016-03-16
LATEST ACTION
2025-04-07
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

CELECOXIBPrescription
CELECOXIB 200MG · CAPSULE · ORAL
CELECOXIBPrescription
CELECOXIB 50MG · CAPSULE · ORAL
CELECOXIBPrescription
CELECOXIB 400MG · CAPSULE · ORAL
CELECOXIBPrescription
CELECOXIB 100MG · CAPSULE · ORAL

Approval history

2025-04-07Labeling · Supplement 10 · standardAP
2025-04-07Labeling · Supplement 37 · standardAP
2025-04-07Labeling · Supplement 19 · standardAP
2025-04-07Labeling · Supplement 23 · standardAP
2025-04-07Labeling · Supplement 13 · standardAP
2025-04-07Labeling · Supplement 9 · standardAP
2023-06-07Labeling · Supplement 21 · standardAP
2016-09-16Labeling · Supplement 3 · standardAP
2016-03-16UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →